Arturas Inčiūra

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients

Arturas Inčiūra, Andrius Simavičius, Elona Juozaitytė et al. · BMC Cancer · 2006 · 51 citations · Full text

Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma

Milda Rudžianskienė, Arturas Inčiūra, Rolandas Gerbutavičius et al. · Strahlentherapie und Onkologie · 2017 · 49 citations · Full text

Early‐stage cervical cancer: agreement between ultrasound and histopathological findings with regard to tumor size and extent of local disease

Adrius Gaurilčikas, Daiva Vaitkienė, Arvydas Čižauskas et al. · Ultrasound in Obstetrics and Gynecology · 2011 · 39 citations · Full text

Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.

V Rudzianskas, Arturas Inčiūra, Elona Juozaitytė et al. · PubMed · 2012 · 29 citations